Indicated for: epilepsy
Route of administration: oral
Substance: tiagabine (antiepileptic)
ATC: N03AG06 (Nervous system | Antiepileptics | Fatty acid derivatives)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may cause drowsiness or reduced alertness.
Tiagabine is an antiepileptic medication used for the treatment of partial seizures, with or without secondary generalization. It works by inhibiting the reuptake of GABA (gamma-aminobutyric acid), an inhibitory neurotransmitter, thereby increasing its levels in the brain and reducing excessive neuronal activity.
The medication is taken orally, usually two to four times daily, as directed by a doctor. The dosage is gradually adjusted to minimize the risk of side effects.
Patients should be monitored for potential side effects, such as dizziness, drowsiness, or confusion. It is important for patients to inform their doctor of any unusual symptoms or the use of other medications.
Common side effects include dizziness, drowsiness, nausea, and irritability. In rare cases, severe reactions such as severe confusion or allergic reactions may occur. Patients should be informed of these risks before starting treatment.